During the First Quarter, Sales of PT. Pyridam Farma Tbk (PYFA) Up 49%
Jakarta, June 3, 2021 - PT. Pyridam Farma Tbk with the issuer name PYFA recorded sales during the first quarter of 2021 increased by 49% compared to the first quarter of 2020. In addition, PYFA earned a net profit of
South Korean Conglomerate Purchased Shares in PT Pyridam Farma Tbk (PYFA)
Jakarta, 29 April 2021 - PT Aldiracita Sekuritas Indonesia has sold part of its ownership in PT Pyridam Farma Tbk (PYFA) to LG International Corp (LGI). LGI is part of the LG Group which is one of the largest conglomerates
LG International Corp (LGI) Signs Cooperation Agreement With PT Pyridam Farma Tbk (PYFA)
[mkdf_inner_row_holder space_between_columns="normal" text_alignment=""][mkdf_inner_row_column column_size="6"] [/mkdf_inner_row_column][mkdf_inner_row_column column_size="6"] LG International Corp (LGI) Signs Cooperation Agreement With PT Pyridam Farma Tbk (PYFA) Jakarta, 29 April 2021 – LG International Corp (LGI), part of the LG Group – one of the largest South Korean conglomerates headquartered in
PT Pyridam Farma Tbk. Enters into A Cooperation Agreement with LG International Corp.
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk. (“Company”) hereby inform that the Company intends to cooperate with LG International Corp. (“LGI”), a
Subsidiary of PT. Pyridam Farma Tbk (PYFA) Signed a Shares Subscription Agreement with Fullerton Healthcare Indonesia Group
Dr. Fitriani Sukri (Director of PT E-Tirta Medical Center), Dr. Rahmaniwati Sulaiman (President Director of PT E Tirta Medical Center), Alain Durand (President director of Fullerton Health Indonesia Group), Yenfrino Gunadi (Director of PT Pyridam Farma Tbk and PT Pyfa
Signing of Four Shares Subscription Agreements by PT Pyfa Investama Medika to Subscribe New Shares in the Fullerton Health Indonesia Group
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk. (“Company”) hereby inform that the Company is the 99.00% shareholder from the total issued and
Positive Performance, Net Profit of PT. Pyridam Farma Tbk (PYFA) Increase 137%
Jakarta, 19 April 2021 - Despite being affected by the Covid-19 pandemic in 2020, the performance of PT. Pyridam Farma Tbk, with the name of the issuer PYFA, recorded a net profit growth of 137% when compared to the previous
AMSI Receives 2,725 Supplement Packages from Pyridam Farma
Jakarta, the Indonesian Cyber Media Association (AMSI) received 2,725 supplement packages from Pyridam Farma to be distributed to AMSI member media in 21 provinces. The General Chairperson of AMSI said that this assistance was valuable for journalists in the field
Pyridam Farma (PYFA) Ready to Enter the Consumer Health Market
Jakarta, March 4, 2021 - The entry of new investors in Pyridam Farma (PYFA) at the end of last year had a positive impact in improving the company's performance. In the first quarter of 2021, Pyridam Farma will be more
Establishment of Four Subsidiaries in Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and the Decision of the Board of Directors of the Indonesia No. Kep. 00015/BEI/01-2021 on the Amendment of Regulation No.